Advertisement

Tumor Biology

, Volume 34, Issue 2, pp 827–836 | Cite as

Progressive growth of a murine T cell lymphoma alters population kinetics and cell viability of macrophages in a tumor-bearing host

  • Pramod K. Gautam
  • Babu N. Maurya
  • Sanjay Kumar
  • Praveen Deepak
  • Sanjay KumarJr
  • Munendra S. Tomar
  • Arbind Acharya
Research Article

Abstract

Tumor progression induces infiltration of immune cell populations at the site of tumor growth. Infiltrated leukocyte population including monocyte and macrophages interacts with tumor cells and tumor microenvironment and results in the suppression of macrophage functions. Impaired functions of macrophages result in the suppression/inhibition of cell-mediated immunity leading to inefficient antitumor immune responses. Impaired macrophage population invariably helps in immune selection of tumor leading to uninterrupted growth and progression in the host. Murine T cell lymphoma designated as Dalton’s lymphoma is highly immunosuppressive and invasive tumor of T cell origin, which completely paralyzes the host’s immune system resulting in a very short life span of the host. Progressive growth of Dalton’s lymphoma (DL) cells has been known to inhibit the release of inflammatory cytokines and effector mediator molecules. In this study, we demonstrate that intraperitoneal transplant of DL cells in normal healthy host induces a rapid increase in macrophage cell population during early stage of tumor progression and progressive decrease in tumor-associated macrophage population and reduced survival of macrophages in advance stage of tumor burden.

Keywords

Dalton’s lymphoma Macrophage Cell viability Conditioned medium Apoptosis 

Abbreviation

IL

Interleukin

TDF

Tumor-derived factor

DL

Dalton’s lymphoma

TAMs

Tumor-associated macrophages

GF

Growth factors

ASR

Anti-sera

Notes

Acknowledgments

The authors are very thankful to RGNF, UGC, New Delhi for student grants to PKG.

Conflicts of interest

None

References

  1. 1.
    Shih JY, Yuai A, Jeremy JW, Chen JJ, Yang PC, et al. Tumor-associated macrophage: its role in cancer invasion and metastasis. J Can Mol. 2006;2(3):101–6.Google Scholar
  2. 2.
    Sarireh BL, Eremin O. Tumor-associated macrophages (TAMS): disordered function, immune suppression and progressive tumor growth. J R Coll Surg. 2000;45:1–16.Google Scholar
  3. 3.
    Parkin J, Ohen B. An overview of the immune system. Lancet. 2001;357:1777–89.PubMedCrossRefGoogle Scholar
  4. 4.
    Forngaleg-Behia EB, Doseff AI. Regulation of monocytes and macrophages cell fate. Front Bios. 2008;14:2413–31.Google Scholar
  5. 5.
    Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Can Res. 2006;66(2):605–12.CrossRefGoogle Scholar
  6. 6.
    Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trend Immunol. 2002;11:49–555.Google Scholar
  7. 7.
    Bingle L, Brown NJ, Lewis CE. The role of tumor-associated macrophages in tumor progression: implications for new anticancer therapies. J Pathol. 2002;3:254–65.CrossRefGoogle Scholar
  8. 8.
    Mahoney KH, Heppner GH. Facs analysis of tumor- associated macrophages replication: differentiation between metastasis and nonmetastasic murine mammary tumor. J leuko Boil. 1987;41:205–11.Google Scholar
  9. 9.
    Solinas G, Germano G, Mantovani A, Allavena AP, et al. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. JJ Leuko Boil. 2009;86:1065–73.CrossRefGoogle Scholar
  10. 10.
    Siveen KS, Kuttan G. Role of macrophage in tumor progression. Immunol Lett. 2009;123:97–102.PubMedCrossRefGoogle Scholar
  11. 11.
    Udaychander M, Meenakshi A, Muthiah R, Sivanandham R, et al. Tumor targeting potential of liposomes encapsulating Ga-67 and antibody to Dalton’s lymphoma associated antigen (anti-DLAA). Int J Radiat Oncol Biol Phys. 1987;13:1713–18.CrossRefGoogle Scholar
  12. 12.
    Khynriam D, Prasad SB. Cisplatin induced genotoxic effects and endogenous glutathione levels in mice bearing ascites Dalton’s lymphoma. Mutat Res. 2003;526:9–18.PubMedCrossRefGoogle Scholar
  13. 13.
    Kumar A, Singh SM. Effect of tumor growth on the blastogenic response of splenocytes: a role of macrophage derived nitric oxide. Immunol Invest. 1996;25:413–23.PubMedCrossRefGoogle Scholar
  14. 14.
    Nardin A, Abastado JP. Macrophages and cancer. Front Biosci. 2008;13:3494–505.PubMedCrossRefGoogle Scholar
  15. 15.
    Klaus DE, Alleva DG, Mullins DW. Tumor-induced immune dysfunction: the macrophage connection. J Leukoc Biol. 1998;64:275–90.Google Scholar
  16. 16.
    Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol. 2005;5:953–64.PubMedCrossRefGoogle Scholar
  17. 17.
    Xian ZY, Shi-Cang Y, Wu B, Bian JG. Contribution of myeloid-derived suppressor cells to tumor-induced immune suppression, angiogenesis, invasion and metastasis. Genomics. 2010;37:423–30.Google Scholar
  18. 18.
    Ben B. Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators. Sem in Cancer Biol. 2006;16:38–52.CrossRefGoogle Scholar
  19. 19.
    Ohono S, Inagawa H, Dhar DK. The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients. Antican Res. 2003;23:5015–22.Google Scholar
  20. 20.
    Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539–45.PubMedCrossRefGoogle Scholar
  21. 21.
    Dolcetti L, Marigo I, Mantelli B, Peranzoni E, Zanovello P, Bronte V. Myeloid-derived suppressor cell role intumor-related inflammation. Cancer Lett. 2008;267:216–25.PubMedCrossRefGoogle Scholar
  22. 22.
    Zamarron BF, Chen W-J. Dual roles of immune cells and their factors in cancer development and progression. Int J Biol Sci. 2011;7(5):651–8.PubMedCrossRefGoogle Scholar
  23. 23.
    Sonda N, Chioda M, Zilio S, Simonato F, Bronte V. Transcription factors in myeloid-derived suppressor cell recruitment and function. Curr Opin Immunol. 2011;23:279–85.PubMedCrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2012

Authors and Affiliations

  • Pramod K. Gautam
    • 1
  • Babu N. Maurya
    • 1
  • Sanjay Kumar
    • 1
  • Praveen Deepak
    • 1
  • Sanjay KumarJr
    • 1
  • Munendra S. Tomar
    • 1
  • Arbind Acharya
    • 1
  1. 1.Department of Zoology, Faculty of ScienceBanaras Hindu UniversityVaranasiIndia

Personalised recommendations